Redistribution of CD163+ CCR2+ Monocytes from Blood Circulation to the Ascites as a Potential Indicator of Progression in High-Grade Serous Ovarian Cancer
Year: 2026
Type: article
Study design: Observational Study
Abstract: This study aimed to identify tumor-specific changes in circulating and ascites-derived monocytes from high-grade serous ovarian carcinoma (HGSOC) patients using flow cytometry, immunohistochemistry, RNA sequencing, and in vitro experiments. Our results demonstrate that the tumor induces a decrease in the total number of circulating monocytes but an increase in the proportion of CD163+ monocytes. Notably, CD206-expressing monocytes were reduced in HGSOC patients, with extremely low CD206 levels in peripheral blood mirroring those in tumor tissues. In contrast, a marked accumulation of CD206-positive monocyte-derived macrophages was observed in malignant ascites. The presence of CCR2 on the monocyte surface further amplified the increase in CD163+ monocytes and reversed the decrease in CD206+ monocytes in cancer patients. Transcriptional levels of CD163 corresponded to protein levels and were elevated in monocytes of HGSOC patients. Moreover, the percentage of CD163+CCR2+ monocytes was decreased in peripheral blood but increased in ascites of patients with progressive disease. A functional migration assay confirmed extensive recruitment of monocytes toward malignant ascites in vitro. Collectively, our findings suggest that the redistribution of CD163+CCR2+ monocytes from blood to malignant ascites may represent a candidate indicator of disease progression in HGSOC patients.
Institutions: Russian Academy of Sciences, National Research Tomsk State University, Tomsk National Research Medical Center, Tomsk Cancer Research Institute, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Liaoning Cancer Hospital & Institute, Heidelberg University, Medizinische Fakultät Mannheim
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
Funder: Russian Science Foundation
Award: G9001398083
OpenAlex ID: W7236843446
